Measuring outcomes in PAH: The gap between the measures that are used and their validity

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 410-416

  Furst, Daniel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Outcome measurements; Pulmonary arterial hypertension; Systemic sclerosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CONFERENCE PAPER; ECHOCARDIOGRAPHY; EXERCISE TEST; OUTCOME ASSESSMENT; PULMONARY HYPERTENSION; SIX MINUTE WALKING TEST; VALIDATION STUDY; ARTERY; ARTICLE; HUMAN; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ARTERIES; HUMANS; HYPERTENSION, PULMONARY; TREATMENT OUTCOME;

EID: 34648832267     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.043     Document Type: Conference Paper

References (22)

1. RAMIREZ, A. & J. VARGA. 2004. Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management.Treat. Respir. Med. 3: 339-352.
2. TORBICKI, A. & M. KURZYNA. 2005. Pulmonary arterial hypertension: evaluation of the newly diagnosed patient. Semin. Respir. Crit. Care Med. 26: 372-378.
3. MORRELL, N.W. 2006. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc. Am. Thorac. Soc. 3: 680-686.
4. DENTON BLACK, C.M. 2004. Pulmonary fibrosis & pulmonary vascular involved in SSc. In Systemic Sclerosis. P.J. Clements & D.E. Furst, Eds.: pp. 184-193. Lippincott, Williams & Wilkins. Philadelphia, PA.
5. ASHERSON, R.A., T.W., HIGENBOTTAM, A.T. DINH-XUAN, et al. 1990. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J. Rheumatol. 17: 1292-1298.
6. STUPI, A.M., V.D. STEEN, G.R. OWENS, et al. 1986. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 29: 515-524.
7. STEEN, V. & T.A. MEDSGER Jr. 2003. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 48: 516-522.
8. KAWUT, S.M., D.B. TAICHMAN, C.L. ARCHER-CHICKO, et al. 2003. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123: 344-350.
9. BOERS, M., P. BROOKS, C.V. STRAND, et al. 1998. The OMERACT filter for outcome measures in rheumatology. J. Rheumatol. 25: 198-199.
10. PEDERSEN, M.R., M.T. FISHER & E.J. VAN BEEK. 2006. MR imaging of the pulmonary vasculature - an update. Eur. Radiol. 16: 1374-1386.
11. WOKHLU, N., V.M. HSU, A. WILSON, et al. 2006. P-wave amplitude and pulmonary artery pressure in scleroderma. J. Electrocardiol. 39: 385-388.
12. ORAVEC R., B.T.J. CARLOS, B. MARKUS, et al. 2005. N-terminal pro-brain natriuretic peptide in the diagnosis of PAH in SSC [Abstract 364]. Arthritis Rheum. 52: S167.
13. ANTIVALLE M., G. RANDISI, M.G. MARRAZZA, et al. 2005. Plasma-NT-Pro BNP, pulmonary function test & 6MWT in the assessment of SSC-related PAH. Arthritis Rheum. 52: s167.
14. STEEN, V.D., G. GRAHAM, C. CONTE, et al. 1992. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum. 35: 765-770.
15. BUCH, M.H., C.P. DENTON, D.E. FURST, et al. 2007. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann. Rheum. Dis. 66: 169-173.
16. BADESCH, D.B., V.F. TAPSON, M.D. MCG OON, et al. 2000. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann. Intern. Med. 132: 425-434.
17. DENTON, C.P., M. HUMBERT, L. RUBIN, et al. 2006. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann. Rheum. Dis. 65: 1336-1340.
18. MCGOON, M., D. GUTTERMAN, V. STEEN, et al. 2004. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126: 14S-34S.
19. DENTON, C.P., J.B. CAILES, G.D. PHILLIPS, et al. 1997. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br. J. Rheumatol. 36: 239-243.
20. CORDRERO, A.C., M.J. LOUREIRO, C. COTRIM, et al. 2006. Detection of pulmonary hypertension in SSc by exercise echocardiography [Abstract 1864]. Arthritis Rheum. 54: S740.
21. ARCASOY, S.M., J.D. CHRISTIE, V.A. FERRARI, et al. 2003. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 167: 735-740.
22. DISTLER, O., F. BEHRENS, D. HUSCHER, et al. 2006. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Rheumatology (Oxford) 45: 1455-1457.